{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:47:35Z","timestamp":1783687655530,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00330-021-08316-8","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:10:54Z","timestamp":1634170254000},"page":"2506-2517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors"],"prefix":"10.1007","volume":"32","author":[{"given":"Seungchul","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-7758","authenticated-orcid":false,"given":"Jung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"8316_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bpg.2013.01.006","volume":"26","author":"M Fraenkel","year":"2012","unstructured":"Fraenkel M, Kim MK, Faggiano A, Valk GD (2012) Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26:691\u2013703","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1\u201318","key":"8316_CR2","first-page":"vii","volume":"40","author":"B Lawrence","year":"2011","unstructured":"Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM (2011) The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 40(1\u201318):vii","journal-title":"Endocrinol Metab Clin North Am"},{"key":"8316_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335\u20131342","journal-title":"JAMA Oncol"},{"key":"8316_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","volume":"16","author":"M Shah","year":"2018","unstructured":"Shah M, Goldner W, Halfdanarson T et al (2018) NCCN clinical practice guidelines in oncology: neuroendocrine and adrenal tumors. J Natl Compr Cancer Netw 16:693\u2013702","journal-title":"J Natl Compr Cancer Netw"},{"key":"8316_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","volume":"42","author":"PL Kunz","year":"2013","unstructured":"Kunz PL, Reidy-Lagunes D, Anthony LB et al (2013) Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 42:557\u2013577","journal-title":"Pancreas"},{"key":"8316_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/jnci\/djs208","volume":"104","author":"G Rindi","year":"2012","unstructured":"Rindi G, Falconi M, Klersy C et al (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764\u2013777","journal-title":"J Natl Cancer Inst"},{"key":"8316_CR7","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1245\/s10434-018-6518-2","volume":"25","author":"CG Gen\u00e7","year":"2018","unstructured":"Gen\u00e7 CG, Falconi M, Partelli S et al (2018) Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67. Ann Surg Oncol 25:2467\u20132474","journal-title":"Ann Surg Oncol"},{"key":"8316_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1530\/EC-19-0282","volume":"8","author":"H Kim","year":"2019","unstructured":"Kim H, Song KB, Hwang DW, Lee JH, Alshammary S, Kim SC (2019) Time-trend and recurrence analysis of pancreatic neuroendocrine tumors. Endocr Connect 8:1052\u20131060","journal-title":"Endocr Connect"},{"key":"8316_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jmri.25756","volume":"47","author":"R Canellas","year":"2018","unstructured":"Canellas R, Lo G, Bhowmik S, Ferrone C, Sahani D (2018) Pancreatic neuroendocrine tumor: correlations between MRI features, tumor biology, and clinical outcome after surgery. J Magn Reson Imaging 47:425\u2013432","journal-title":"J Magn Reson Imaging"},{"key":"8316_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/OTT.S127803","volume":"10","author":"C Guo","year":"2017","unstructured":"Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z (2017) Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1\/2 tumors. Onco Targets Ther 10:1465\u20131474","journal-title":"Onco Targets Ther"},{"key":"8316_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14139","author":"J Kang","year":"2018","unstructured":"Kang J, Ryu JK, Son JH et al (2018) Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.14139","journal-title":"J Gastroenterol Hepatol"},{"key":"8316_CR12","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ejrad.2015.05.005","volume":"84","author":"K Takumi","year":"2015","unstructured":"Takumi K, Fukukura Y, Higashi M et al (2015) Pancreatic neuroendocrine tumors: correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol 84:1436\u20131443","journal-title":"Eur J Radiol"},{"key":"8316_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11604-017-0627-x","volume":"35","author":"F Toshima","year":"2017","unstructured":"Toshima F, Inoue D, Komori T et al (2017) Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Jpn J Radiol 35:242\u2013253","journal-title":"Jpn J Radiol"},{"key":"8316_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00330-014-3532-z","volume":"25","author":"DW Kim","year":"2015","unstructured":"Kim DW, Kim DW, Kim HJ et al (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1\/2 neuroendocrine tumour. Eur Radiol 25:1375\u20131383","journal-title":"Eur Radiol"},{"key":"8316_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1148\/rg.306105523","volume":"30","author":"RB Lewis","year":"2010","unstructured":"Lewis RB, Lattin GE Jr, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30:1445\u20131464","journal-title":"Radiographics"},{"key":"8316_CR16","doi-asserted-by":"crossref","unstructured":"d\u2019Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors","DOI":"10.1148\/radiol.2501080291"},{"key":"8316_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00330-015-3941-7","volume":"26","author":"JH Kim","year":"2016","unstructured":"Kim JH, Eun HW, Kim YJ, Lee JM, Han JK, Choi BI (2016) Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol 26:1338\u20131347","journal-title":"Eur Radiol"},{"key":"8316_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/hpb.12139","volume":"16","author":"DJ Worhunsky","year":"2014","unstructured":"Worhunsky DJ, Krampitz GW, Poullos PD et al (2014) Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford) 16:304\u2013311","journal-title":"HPB (Oxford)"},{"key":"8316_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"8316_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08007-4","author":"M Dioguardi Burgio","year":"2021","unstructured":"Dioguardi Burgio M, Cros J, Panvini N et al (2021) Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08007-4","journal-title":"Eur Radiol"},{"key":"8316_CR21","doi-asserted-by":"publisher","first-page":"W482","DOI":"10.2214\/AJR.10.5428","volume":"197","author":"S Kawamoto","year":"2011","unstructured":"Kawamoto S, Shi C, Hruban RH et al (2011) Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. AJR Am J Roentgenol 197:W482-488","journal-title":"AJR Am J Roentgenol"},{"key":"8316_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.13364","volume":"87","author":"WT Zandee","year":"2017","unstructured":"Zandee WT, van Adrichem RC, Kamp K, Feelders RA, van Velthuysen MF, de Herder WW (2017) Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours. Clin Endocrinol (Oxf) 87:165\u2013170","journal-title":"Clin Endocrinol (Oxf)"},{"key":"8316_CR23","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s00261-017-1212-6","volume":"42","author":"C Kim","year":"2017","unstructured":"Kim C, Byun JH, Hong SM et al (2017) A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis. Abdom Radiol (NY) 42:2835\u20132842","journal-title":"Abdom Radiol (NY)"},{"key":"8316_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0016-5085(03)01198-3","volume":"125","author":"AM Marion-Audibert","year":"2003","unstructured":"Marion-Audibert AM, Barel C, Gouysse G et al (2003) Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 125:1094\u20131104","journal-title":"Gastroenterology"},{"key":"8316_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000090026","volume":"6","author":"M Rodallec","year":"2006","unstructured":"Rodallec M, Vilgrain V, Couvelard A et al (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6:77\u201385","journal-title":"Pancreatology"},{"key":"8316_CR26","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.3892\/ol.2017.6029","volume":"13","author":"C Guo","year":"2017","unstructured":"Guo C, Zhuge X, Chen X, Wang Z, Xiao W, Wang Q (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1\/G2 pancreatic neuroendocrine tumors. Oncol Lett 13:4141\u20134146","journal-title":"Oncol Lett"},{"key":"8316_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.surg.2011.02.022","volume":"150","author":"R Bettini","year":"2011","unstructured":"Bettini R, Partelli S, Boninsegna L et al (2011) Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 150:75\u201382","journal-title":"Surgery"},{"key":"8316_CR28","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00330-013-2929-4","volume":"23","author":"R Manfredi","year":"2013","unstructured":"Manfredi R, Bonatti M, Mantovani W et al (2013) Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. Eur Radiol 23:3029\u20133039","journal-title":"Eur Radiol"},{"key":"8316_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2214\/AJR.17.18417","volume":"210","author":"R Canellas","year":"2018","unstructured":"Canellas R, Burk KS, Parakh A, Sahani DV (2018) Prediction of pancreatic neuroendocrine tumor grade based on CT features and texture analysis. AJR Am J Roentgenol 210:341\u2013346","journal-title":"AJR Am J Roentgenol"},{"key":"8316_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey JN (2018) 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol 25:845\u2013847","journal-title":"Ann Surg Oncol"},{"key":"8316_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/030089161009600532","volume":"96","author":"G Rindi","year":"2010","unstructured":"Rindi G (2010) The ENETS guidelines: the new TNM classification system. Tumori 96:806\u2013809","journal-title":"Tumori"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08316-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T17:29:23Z","timestamp":1647278963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["8316"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08316-8","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Jung Hoon Kim, M.D.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Seungchul Han M.D. has significant statistical expertise, and no complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board. This study was approved by our Institutional Review Board, and informed patient consent was waived due to the retrospective nature of our study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (IRB; No. 1808\u2013146-967).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}